355 related articles for article (PubMed ID: 31179525)
1. Alpha-1 Antitrypsin Deficiency and Accelerated Aging: A New Model for an Old Disease?
Crossley D; Stockley R; Sapey E
Drugs Aging; 2019 Sep; 36(9):823-840. PubMed ID: 31179525
[TBL] [Abstract][Full Text] [Related]
2. Monocytes and Macrophages in Alpha-1 Antitrypsin Deficiency.
Belchamber KBR; Walker EM; Stockley RA; Sapey E
Int J Chron Obstruct Pulmon Dis; 2020; 15():3183-3192. PubMed ID: 33311976
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil Modulation in Alpha-1 Antitrypsin Deficiency.
Sapey E
Chronic Obstr Pulm Dis; 2020 Jul; 7(3):247-259. PubMed ID: 32697897
[TBL] [Abstract][Full Text] [Related]
4. The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.
Lascano JE; Campos MA
Postgrad Med; 2017 Nov; 129(8):889-895. PubMed ID: 28929906
[TBL] [Abstract][Full Text] [Related]
5. The Autophagy Pathway: A Critical Route in the Disposal of Alpha 1-Antitrypsin Aggregates That Holds Many Mysteries.
Leon C; Bouchecareilh M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33668611
[TBL] [Abstract][Full Text] [Related]
6. Hereditary alpha-1-antitrypsin deficiency and its clinical consequences.
Fregonese L; Stolk J
Orphanet J Rare Dis; 2008 Jun; 3():16. PubMed ID: 18565211
[TBL] [Abstract][Full Text] [Related]
7. Pathophysiology of Alpha-1 Antitrypsin Lung Disease.
Kalfopoulos M; Wetmore K; ElMallah MK
Methods Mol Biol; 2017; 1639():9-19. PubMed ID: 28752442
[TBL] [Abstract][Full Text] [Related]
8. Alpha-1 antitrypsin augmentation therapy corrects accelerated neutrophil apoptosis in deficient individuals.
Hurley K; Lacey N; O'Dwyer CA; Bergin DA; McElvaney OJ; O'Brien ME; McElvaney OF; Reeves EP; McElvaney NG
J Immunol; 2014 Oct; 193(8):3978-91. PubMed ID: 25217166
[TBL] [Abstract][Full Text] [Related]
9. The Role of Neutrophils in Alpha-1 Antitrypsin Deficiency.
McCarthy C; Reeves EP; McElvaney NG
Ann Am Thorac Soc; 2016 Aug; 13 Suppl 4():S297-304. PubMed ID: 27564664
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterisation of eight novel SERPINA1 Null mutations.
Ferrarotti I; Carroll TP; Ottaviani S; Fra AM; O'Brien G; Molloy K; Corda L; Medicina D; Curran DR; McElvaney NG; Luisetti M
Orphanet J Rare Dis; 2014 Nov; 9():172. PubMed ID: 25425243
[TBL] [Abstract][Full Text] [Related]
11. The BLT1 Inhibitory Function of α-1 Antitrypsin Augmentation Therapy Disrupts Leukotriene B4 Neutrophil Signaling.
O'Dwyer CA; O'Brien ME; Wormald MR; White MM; Banville N; Hurley K; McCarthy C; McElvaney NG; Reeves EP
J Immunol; 2015 Oct; 195(8):3628-41. PubMed ID: 26371243
[TBL] [Abstract][Full Text] [Related]
12. Cigarette smoke exposed airway epithelial cell-derived EVs promote pro-inflammatory macrophage activation in alpha-1 antitrypsin deficiency.
Khodayari N; Oshins R; Mehrad B; Lascano JE; Qiang X; West JR; Holliday LS; Lee J; Wiesemann G; Eydgahi S; Brantly M
Respir Res; 2022 Sep; 23(1):232. PubMed ID: 36068572
[TBL] [Abstract][Full Text] [Related]
13. Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals.
Hawkins P; Sya J; Hup NK; Murphy MP; McElvaney NG; Reeves EP
Medicina (Kaunas); 2021 Aug; 57(8):. PubMed ID: 34441020
[No Abstract] [Full Text] [Related]
14. Activation of complement component 3 is associated with airways disease and pulmonary emphysema in alpha-1 antitrypsin deficiency.
O'Brien ME; Fee L; Browne N; Carroll TP; Meleady P; Henry M; McQuillan K; Murphy MP; Logan M; McCarthy C; McElvaney OJ; Reeves EP; McElvaney NG
Thorax; 2020 Apr; 75(4):321-330. PubMed ID: 31959730
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes following treatment with alpha 1-proteinase inhibitor for COPD associated with alpha-1 antitrypsin deficiency: a look at the evidence.
Rahaghi FF; Miravitlles M
Respir Res; 2017 May; 18(1):105. PubMed ID: 28558837
[TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-α driven inflammation in alpha-1 antitrypsin deficiency: a new model of pathogenesis and treatment.
Hurley K; Reeves EP; Carroll TP; McElvaney NG
Expert Rev Respir Med; 2016 Feb; 10(2):207-22. PubMed ID: 26634397
[TBL] [Abstract][Full Text] [Related]
17. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of inhaled human α-1 antitrypsin in people with α-1 antitrypsin deficiency-related emphysema.
Franciosi AN; McCarthy C; McElvaney NG
Expert Rev Respir Med; 2015 Apr; 9(2):143-51. PubMed ID: 25598013
[TBL] [Abstract][Full Text] [Related]
19. Recurrence of emphysema post-lung transplantation in a patient with alpha 1 antitrypsin deficiency (AATD).
Ataya A
Respir Med Case Rep; 2020; 31():101309. PubMed ID: 33304809
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1 Antitrypsin-Deficient Macrophages Have Impaired Efferocytosis of Apoptotic Neutrophils.
Lee J; Lu Y; Oshins R; West J; Moneypenny CG; Han K; Brantly ML
Front Immunol; 2020; 11():574410. PubMed ID: 33329539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]